Log in

NASDAQ:STROSutro Biopharma Earnings Date, Estimates & History

$9.83
-0.13 (-1.31 %)
(As of 06/5/2020 04:00 PM ET)
Add
Compare
Today's Range
$9.71
Now: $9.83
$10.18
50-Day Range
$8.15
MA: $9.83
$11.05
52-Week Range
$6.00
Now: $9.83
$12.75
Volume90,852 shs
Average Volume133,249 shs
Market Capitalization$228.35 million
P/E RatioN/A
Dividend YieldN/A
Beta0.43

Earnings

Sutro Biopharma (NASDAQ:STRO) Earnings Information

Sutro Biopharma last posted its quarterly earnings data on May 11th, 2020. The reported ($0.84) EPS for the quarter, missing the consensus estimate of ($0.69) by $0.15. The firm had revenue of $7.15 million for the quarter, compared to analyst estimates of $11.16 million. Sutro Biopharma has generated ($2.43) earnings per share over the last year. Sutro Biopharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 12th, 2020 based off prior year's report dates.

Sutro Biopharma Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Sutro Biopharma (NASDAQ:STRO) Earnings Estimates

2020 EPS Consensus Estimate: ($3.06)
2021 EPS Consensus Estimate: ($4.43)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20204($0.94)($0.58)($0.74)
Q2 20204($0.99)($0.47)($0.73)
Q3 20204($1.05)($0.48)($0.75)
Q4 20204($1.10)($0.53)($0.84)
Q1 20212($2.69)($0.71)($1.70)
Q2 20211($0.79)($0.79)($0.79)
Q3 20211($0.93)($0.93)($0.93)
Q4 20211($1.01)($1.01)($1.01)

Sutro Biopharma (NASDAQ STRO) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
8/12/2020
(Estimated)
       
5/11/2020Q1 2020($0.69)($0.84)($0.84)$11.16 million$7.15 millionN/A
3/16/202012/31/2019($0.69)($0.64)($0.64)$9.33 million$11.31 millionN/A
11/8/2019Q3($0.6540)($0.56)($0.56)$8.88 million$12.28 millionN/A
8/14/2019Q2 2019($0.5520)($0.60)($0.60)$8.38 million$10.53 millionN/A
5/15/2019Q1 2019($0.60)($0.62)($0.62)$8.92 million$8.63 millionN/A
11/14/2018Q3($0.1580)($21.26)($21.26)$7.84 millionN/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 6/6/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.